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Lampiran 3. Spreadsheet data 
no CM usia jenis kelamin tipe admisi dasar penyakitnya 
B010186 70 L medis pneumonia 
C227854 66 P medis bronchopneumonia 
C264434 34 P operasi pneumonia, ARDS berat 
C231593 72 P medis pneumonia 
C365140 59 P medis pneumonia, ISK 
C419668 65 L medis multiple nefrolithiasis 
C250304 58 P medis ulkus pedis sinistra (akibat DMT II) dan pneumonia 
C454023 57 L medis pneumonia 
C338161 54 L medis pneumonia 
C464780 51 L medis pneumonia, infeksi kaki diabetik 
C466367 47 P operasi Ca squamous paru sinistra 
C466582 31 L medis encephalitis 
C469884 68 L operasi post nefrostomi + TUR buli 
C472160 42 P operasi post relaparotomy Ca sigmoid 
C473073 34 L medis pneumonia 
C473289 80 L medis encephalitis 
C480548 28 P operasi gawat janin saat operasi SC kemudian kejang 
C399076 76 L medis pneumonia 
C488221 72 P medis pneumonia 
C489189 74 L operasi post laparotomy ec perforasi gaster 
C503632 59 P medis pneumonia 
C520688 73 P operasi ARDS 
C523095 45 P medis tuberculosis paru BTA positif 
C528654 33 P medis pneumonia 
C528717 72 L medis pneumonia 
C529282 72 P medis pneumonia 
C540639 78 L medis bronchopneumonia 
C565134 48 L medis abses paru dengan pneumonia 




no CM fokus infeksi 
Skor APACHE 
II skor Qsofa leukosit Hb Ht platelet glukosa albumin 
B010186 sis respirasi 33 3 11.1 10.6 30.7 211 419 2.5  
C227854 sis respirasi 27 2 5.12 9.87 29.5 42.2 600 3.4  
C264434 sis respirasi, post histerotomi 24 2 36.2 8 24.3 191.2 164 2.6  
C231593 sis respirasi 16 2 11.82 8.52 25.1 314.3 121 2.5  
C365140 sis respirasi, sis genitourinarius 19 2 36 8.4 24 94.7 112 1.8  
C419668 sis genitourinarius 16 1 13.6 12.1 35.4 275 142 4.1  
C250304 kulit dan jar lunak dan sis respirasi 17 0 20.55 9.34 27.6 217.1 154 1.8  
C454023 sis respirasi 19 1 7.5 6.7 19.3 127.5 203 2.2  
C338161 sis respirasi 15 2 9.9 10.5 31.7 164 104 2.8  
C464780 sis respirasi, sis endokrin 24 2 27.3 8.4 23.9 179.9 440 1.4  
C466367 sis respirasi 8 0 22.8 14.2 42.5 294.6 163 2.4  
C466582 sis saraf 10 2 19.8 15.1 43 310.9 126 4.2  
C469884 sis genitourinarius 28 1 23.9 9.7 28.4 217.4 147 2.4  
C472160 sis abdomen/ digestivus 17 3 25 6 18.2 382 84 1.3  
C473073 sis respirasi 20 2 10.4 22.3 64.6 119.8 207 3.8  
C473289 sis saraf 18 2 10.9 14.5 42 128.9 144 2.8  
C480548 sis genitourinarius 28 1 45 11.4 33 267.8 131 2.7  
C399076 sis respirasi 28 2 6.7 12.9 39.8 100 92 2.4  
C488221 sis respirasi 13 1 8.9 8.9 24.8 83 162 2.4  
C489189 sis abdomen/digestivus 20 1 8.3 9.5 27.3 317.3 221 1.9  
C503632 sis respirasi 28 2 30.8 7.7 22.5 283 81 1.2  
C520688 sis respirasi 21 2 16.2 9.2 26.6 86.9 111 2.5  
C523095 sis respirasi 10 3 18.7 10.3 34.6 326 147 3.1  
C528654 sis respirasi 10 2 9.96 9.21 26.1 118 94 3.3  
C528717 sis respirasi 12 2 15.7 15.6 42.1 40.7 208 2.3  
C529282 sis respirasi 16 2 14.3 14.4 45.6 119 224 3.7  
C540639 sis respirasi 32 2 27.1 10.5 31.5 257 83 1.8  
C565134 sis respirasi 16 1 16.2 10.4 31.6 688 161 2.3  





no CM kreatinin sistolik HR RR PaO2/FiO2 diagnosis komorbid mortalitas 
B010186 3.6 100 105 24 311.7 SEPSIS ada meninggal 
C227854 0.5 140 106 30 412.3 SEPSIS ada meninggal 
C264434 3.1 170 100 40 545 SEPSIS ada meninggal 
C231593 0.6 100 80 12 215.63 SEPSIS tidak meninggal 
C365140 4.63 137 102 24 134.4 SEPSIS ada meninggal 
C419668 4.6 120 120 32 239.23 SEPSIS ada meninggal 
C250304 4.55 140 84 20 195 SEPSIS ada meninggal 
C454023 1.38 120 115 14 320 SEPSIS ada meninggal 
C338161 1.4 70 120 12 298 SEPSIS ada meninggal 
C464780 3.76 110 96 30 384.1 SEPSIS ada meninggal 
C466367 0.45 159 112 12 216 SEPSIS ada meninggal 
C466582 0.61 108 77 20 518.75 SEPSIS ada meninggal 
C469884 5.79 130 84 20 332 SEPSIS ada meninggal 
C472160 0.48 70 87 40 134 SEPSIS tidak meninggal 
C473073 3.32 135 130 24 293.75 SEPSIS ada meninggal 
C473289 3.25 190 80 28 138.46 SEPSIS ada meninggal 
C480548 1.33 157 154 18 257.14 SEPSIS tidak meninggal 
C399076 10.32 235 128 28 131.67 SEPSIS ada meninggal 
C488221 0.82 110 86 16 422 SEPSIS ada meninggal 
C489189 2.37 163 111 23 417.31 SEPSIS tidak meninggal 
C503632 2.29 140 81 30 91.43 SEPSIS ada meninggal 
C520688 1.31 152 91 24 467.5 SEPSIS ada meninggal 
C523095 0.69 106 124 24 396.67 SEPSIS ada meninggal 
C528654 0.8 160 140 30 174.67 SEPSIS ada meninggal 
C528717 0.79 106 99 33 240 SEPSIS ada meninggal 
C529282 1.52 136 100 30 307.7 SEPSIS ada meninggal 
C540639 10.3 117 102 26 387.5 SEPSIS ada meninggal 
C565134 0.86 120 114 35 160.28 SEPSIS ada meninggal 




no CM usia 
jenis 
kelamin tipe admisi dasar penyakitnya 
C565710 57 P operasi post relaparotomy a.i fistel enterokutan dan repair stoma --> peritonitis 
C405055 55 P operasi pneumonia 
C409922 79 L medis pyopneumothorax 
C008942 51 P medis *selulitis pedis sinistra 
C462735 52 P operasi pneumonia 
C473082 50 P operasi malignant neoplasma of abdominal part of esophagus 
C473119 69 P operasi Ca recti 
C474099 21 P operasi fraktur pelvis terbuka yang dilakukan debridement 
C372024 65 P medis pneumonia 
C401496 58 L medis hematemesis melena 
C508302 56 L medis ca hipofaring post kemoterapi 
C523373 41 L operasi post operasi debridement pada fraktur terbuka di daerah tibia dan fibula 
A549513 76 P medis pneumonia 
A565232 62 L medis pneumonia 
C566903 72 P operasi abses mandibula 
C095239 61 L operasi anal fistula 
C551480 48 L medis phlebitis and thrombophlebitis of other deep vessels of lower extremities 
C552111 51 P medis pneumonia 










no CM fokus infeksi 
Skor APACHE 
II skor Qsofa leukosit Hb Ht platelet glukosa albumin 
C565710 sis abdomen/digestivus 19 2 30.2 12.8 38.3 172 153 1.8 
C405055 sis respirasi 22 2 24.68 9.47 28.7 189.4 110 2.8 
C409922 sis respirasi 15 2 25.72 10.23 32 184 288 3 
C008942 kulit dan jar lunak 14 1 36.46 13 41.3 282.9 246 2.1 
C462735 sis respirasi, post operasi jantung (DVR) 7 2 12.2 11.7 33.8 126.7 134 2.9 
C473082 sis abdomen/digestivus 13 0 32.2 10.1 30.7 608.2 50 2.1 
C473119 sis abdomen/digestivus 10 1 26.4 12.5 36.9 376.4 65 2 
C474099 *kulit dan jar lunak(?) 6 1 6.27 10.7 29.5 108 142 2.1 
C372024 sis respirasi 27 1 19.36 8.79 25.3 59.9 49 1.6 
C401496 sis abdomen/digestivus 18 2 12.2 13.1 41.4 33 178 2.4 
C508302 sis respirasi 19 1 78.4 10.3 28.5 14 105 3.2 
C523373 *kulit dan jar lunak(?) 26 3 3.88 5.7 17 43.4 13 1.2 
A549513 sis respirasi 14 2 17.1 10.6 32 264 140 3.2 
A565232 sis respirasi 9 0 10.7 11.3 32.6 45.8 169 3.1 
C566903 kulit dan jar lunak 13 0 23.2 8.14 22.2 342 441 2.3 
C095239 sis digestivus 10 2 17.2 11.1 34.9 267 589 2.8 
C551480 * 20 3 11.1 13.1 37.7 14 145 1.5 
C552111 sis respirasi 11 2 7.7 10.5 34.2 257 208 2.1 










no CM kreatinin sistolik HR RR PaO2/FiO2 diagnosis komorbid mortalitas 
C565710 1 112 98 23 354 SEPSIS tidak meninggal 
C405055 0.85 168 75 23 343.2 SEPSIS ada meninggal 
C409922 0.9 164 126 30 121.67 SEPSIS ada meninggal 
C008942 2.52 110 80 20 242.2 SYOK SEPSIS ada meninggal 
C462735 0.66 90 91 12 420 SYOK SEPSIS tidak meninggal 
C473082 3 120 80 20 306.67 SYOK SEPSIS ada meninggal 
C473119 0.56 128 90 28 290 SYOK SEPSIS ada meninggal 
C474099 0.57 90 100 15 315.63 SYOK SEPSIS tidak meninggal 
C372024 2.27 118 115 17 304 SYOK SEPSIS ada meninggal 
C401496 1.4 140 108 30 86.25 SYOK SEPSIS ada meninggal 
C508302 0.65 140 150 25 58.57 SYOK SEPSIS ada meninggal 
C523373 2.79 90 117 27 484 SYOK SEPSIS ada meninggal 
A549513 1.2 90 112 26 165 SEPSIS ada hidup 
A565232 6.19 120 112 20 503.125 SEPSIS ada hidup 
C566903 1.4 120 92 20 571.428571 SEPSIS ada hidup 
C095239 1.87 100 100 28 243.75 SEPSIS ada hidup 
C551480 4.8 90 119 30 260.909091 SEPSIS ada hidup 
C552111 1 126 100 47 475 SEPSIS ada hidup 







Lampiran 4. Hasil analisis data 
 
Hubungan usia dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
usia * mortalitas 47 100.0% 0 0.0% 47 100.0% 
usia * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
usia 
tua 14 2 16 
muda 26 5 31 
Total 40 7 47 
Chi-Square Tests 








 1 .741   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .112 1 .738   
Fisher's Exact Test    1.000 .553 
Linear-by-Linear Association .107 1 .743   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.38. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for usia (tua / 
muda) 
1.346 .231 7.855 
For cohort mortalitas = 
meninggal 
1.043 .820 1.328 
For cohort mortalitas = hidup .775 .169 3.561 







Hubungan jenis kelamin dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
jenis kelamin * mortalitas 47 100.0% 0 0.0% 47 100.0% 
jenis kelamin * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
jenis kelamin 
Laki - laki 18 3 21 
Perempuan 22 4 26 
Total 40 7 47 
Chi-Square Tests 








 1 .916   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .011 1 .916   
Fisher's Exact Test    1.000 .623 
Linear-by-Linear Association .011 1 .917   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.13. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for jenis kelamin 
(Laki - laki / Perempuan) 
1.091 .216 5.520 
For cohort mortalitas = 
meninggal 
1.013 .797 1.287 
For cohort mortalitas = hidup .929 .233 3.699 








Hubungan fokus infeksi dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
fokus infeksi * mortalitas 47 100.0% 0 0.0% 47 100.0% 
fokus infeksi * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
fokus infeksi 
sistem respirasi 25 3 28 
lain - lain 15 4 19 
Total 40 7 47 
Chi-Square Tests 








 1 .329   
Continuity Correction
b
 .313 1 .576   
Likelihood Ratio .936 1 .333   
Fisher's Exact Test    .417 .285 
Linear-by-Linear Association .934 1 .334   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.83. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for fokus infeksi 
(sistem respirasi / lain - lain) 
2.222 .436 11.320 
For cohort mortalitas = 
meninggal 
1.131 .867 1.475 
For cohort mortalitas = hidup .509 .128 2.021 







Hubungan skor APACHE II dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
skor APACHE II * mortalitas 47 100.0% 0 0.0% 47 100.0% 
skor APACHE II * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
skor APACHE II 
>=10 37 6 43 
<10 3 1 4 
Total 40 7 47 
Chi-Square Tests 








 1 .553   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .308 1 .579   
Fisher's Exact Test    .488 .488 
Linear-by-Linear Association .345 1 .557   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .60. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for skor APACHE 
II (>=10 / <10) 
2.056 .182 23.162 
For cohort mortalitas = 
meninggal 
1.147 .643 2.046 
For cohort mortalitas = hidup .558 .088 3.559 








Hubungan skor qSOFA dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
skor qSOFA * mortalitas 47 100.0% 0 0.0% 47 100.0% 
skor qSOFA * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
skor qSOFA 
>=2 25 5 30 
<2 15 2 17 
Total 40 7 47 
Chi-Square Tests 








 1 .650   
Continuity Correction
b
 .001 1 .978   
Likelihood Ratio .212 1 .645   
Fisher's Exact Test    1.000 .501 
Linear-by-Linear Association .201 1 .654   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.53. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for skor qSOFA 
(>=2 / <2) 
.667 .115 3.876 
For cohort mortalitas = 
meninggal 
.944 .746 1.196 
For cohort mortalitas = hidup 1.417 .307 6.530 








Hubungan kadar leukosit dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
kadar leukosit * mortalitas 47 100.0% 0 0.0% 47 100.0% 
kadar leukosit * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
kadar leukosit 
tidak normal 30 4 34 
normal 10 3 13 
Total 40 7 47 
Chi-Square Tests 








 1 .330   
Continuity Correction
b
 .267 1 .606   
Likelihood Ratio .885 1 .347   
Fisher's Exact Test    .377 .291 
Linear-by-Linear Association .929 1 .335   
N of Valid Cases 47     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.94. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for kadar leukosit 
(tidak normal / normal) 
2.250 .428 11.824 
For cohort mortalitas = 
meninggal 
1.147 .831 1.583 
For cohort mortalitas = hidup .510 .132 1.974 








Hubungan kadar hemoglobin dan hematokrit dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
kadar hb dan ht * mortalitas 47 100.0% 0 0.0% 47 100.0% 
kadar hb dan ht * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
kadar hb dan ht 
tidak normal 30 6 36 
normal 10 1 11 
Total 40 7 47 
Chi-Square Tests 








 1 .537   
Continuity Correction
b
 .018 1 .894   
Likelihood Ratio .418 1 .518   
Fisher's Exact Test    1.000 .473 
Linear-by-Linear Association .373 1 .541   
N of Valid Cases 47     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.64. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for kadar hb dan 
ht (tidak normal / normal) 
.500 .054 4.672 
For cohort mortalitas = 
meninggal 
.917 .723 1.162 
For cohort mortalitas = hidup 1.833 .247 13.634 








Hubungan jumlah trombosit dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
trombosit * mortalitas 47 100.0% 0 0.0% 47 100.0% 
trombosit * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
trombosit 
tidak normal 19 3 22 
normal 21 4 25 
Total 40 7 47 
Chi-Square Tests 








 1 .820   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .052 1 .820   
Fisher's Exact Test    1.000 .574 
Linear-by-Linear Association .050 1 .822   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.28. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for trombosit 
(tidak normal / normal) 
1.206 .239 6.099 
For cohort mortalitas = 
meninggal 
1.028 .810 1.305 
For cohort mortalitas = hidup .852 .214 3.398 








Hubungan kadar glukosa dalam darah dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
kadar glukosa dalam darah * 
mortalitas 
47 100.0% 0 0.0% 47 100.0% 
kadar glukosa dalam darah * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
kadar glukosa dalam darah 
tidak normal 28 4 32 
normal 12 3 15 
Total 40 7 47 
Chi-Square Tests 








 1 .501   
Continuity Correction
b
 .055 1 .815   
Likelihood Ratio .435 1 .509   
Fisher's Exact Test    .664 .394 
Linear-by-Linear Association .444 1 .505   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.23. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for kadar glukosa 
dalam darah (tidak normal / 
normal) 
1.750 .339 9.045 
For cohort mortalitas = 
meninggal 
1.094 .823 1.454 
For cohort mortalitas = hidup .625 .160 2.449 







Hubungan kadar albumin dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
kadar albumin * mortalitas 47 100.0% 0 0.0% 47 100.0% 
kadar albumin * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
kadar albumin 
Tidak normal 34 7 41 
normal 6 0 6 
Total 40 7 47 
Chi-Square Tests 








 1 .273   
Continuity Correction
b
 .234 1 .629   
Likelihood Ratio 2.083 1 .149   
Fisher's Exact Test    .571 .357 
Linear-by-Linear Association 1.178 1 .278   
N of Valid Cases 47     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is .89. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
For cohort mortalitas = 
meninggal 
.829 .722 .953 










Hubungan kadar kreatinin serum dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
kadar kreatinin serum * 
mortalitas 
47 100.0% 0 0.0% 47 100.0% 
kadar kreatinin serum * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
kadar kreatinin serum 
tidak normal 27 5 32 
normal 13 2 15 
Total 40 7 47 
Chi-Square Tests 








 1 .837   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .043 1 .836   
Fisher's Exact Test    1.000 .606 
Linear-by-Linear Association .041 1 .839   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.23. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for kadar 
kreatinin serum (tidak normal 
/ normal) 
.831 .142 4.869 
For cohort mortalitas = 
meninggal 
.974 .760 1.248 
For cohort mortalitas = hidup 1.172 .256 5.362 








Hubungan tekanan darah sistolik dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
sistolik * mortalitas 47 100.0% 0 0.0% 47 100.0% 
sistolik * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
sistolik 
tidak normal 22 2 24 
normal 18 5 23 
Total 40 7 47 
Chi-Square Tests 








 1 .197   
Continuity Correction
b
 .776 1 .379   
Likelihood Ratio 1.708 1 .191   
Fisher's Exact Test    .245 .190 
Linear-by-Linear Association 1.630 1 .202   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.43. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for sistolik (tidak 
normal / normal) 
3.056 .529 17.657 
For cohort mortalitas = 
meninggal 
1.171 .915 1.499 
For cohort mortalitas = hidup .383 .082 1.782 







Hubungan frekuensi denyut jantung dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
denyut jantung * mortalitas 47 100.0% 0 0.0% 47 100.0% 
denyut jantung * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
denyut jantung 
Tidak normal 20 4 24 
normal 20 3 23 
Total 40 7 47 
Chi-Square Tests 








 1 .727   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .122 1 .727   
Fisher's Exact Test    1.000 .525 
Linear-by-Linear Association .119 1 .730   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.43. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for denyut 
jantung (tidak normal/ 
normal) 
.750 .148 3.791 
For cohort mortalitas = 
meninggal 
.958 .755 1.217 
For cohort mortalitas = hidup 1.278 .320 5.096 







Hubungan laju pernafasan dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
laju pernafasan * mortalitas 47 100.0% 0 0.0% 47 100.0% 
laju pernafasan * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
laju pernafasan 
Tidak normal 26 4 30 
normal 14 3 17 
Total 40 7 47 
Chi-Square Tests 








 1 .690   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .156 1 .693   
Fisher's Exact Test    .692 .499 
Linear-by-Linear Association .156 1 .693   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.53. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for laju 
pernafasan (tidak normal/ 
normal) 
1.393 .272 7.122 
For cohort mortalitas = 
meninggal 
1.052 .811 1.366 
For cohort mortalitas = hidup .756 .191 2.984 







Hubungan rasio PaO2/FiO2 dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
rasio PaO2/FiO2 * mortalitas 47 100.0% 0 0.0% 47 100.0% 
rasio PaO2/FiO2 * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
rasio PaO2/FiO2 
tidak normal 22 3 25 
normal 18 4 22 
Total 40 7 47 
Chi-Square Tests 








 1 .553   
Continuity Correction
b
 .034 1 .854   
Likelihood Ratio .352 1 .553   
Fisher's Exact Test    .690 .426 
Linear-by-Linear Association .345 1 .557   
N of Valid Cases 47     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.28. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for rasio 
PaO2/FiO2 (tidak normal / 
normal) 
1.630 .322 8.246 
For cohort mortalitas = 
meninggal 
1.076 .842 1.373 
For cohort mortalitas = hidup .660 .166 2.631 







Hubungan komorbid dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
komorbiditas * mortalitas 47 100.0% 0 0.0% 47 100.0% 
komorbiditas * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
komorbiditas 
ada 33 6 39 
tidak ada 7 1 8 
Total 40 7 47 
Chi-Square Tests 








 1 .835   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .045 1 .832   
Fisher's Exact Test    1.000 .660 
Linear-by-Linear Association .043 1 .836   
N of Valid Cases 47     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.19. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for komorbiditas 
(ada / tidak ada) 
.786 .081 7.595 
For cohort mortalitas = 
meninggal 
.967 .721 1.298 
For cohort mortalitas = hidup 1.231 .171 8.875 






Hubungan tipe admisi dengan kematian 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
tipe admisi * mortalitas 47 100.0% 0 0.0% 47 100.0% 
tipe admisi * mortalitas Crosstabulation 
Count   
 mortalitas Total 
meninggal hidup 
tipe admisi 
bedah 11 2 13 
Nonbedah 29 5 34 
Total 40 7 47 
Chi-Square Tests 








 1 .953   
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .003 1 .954   
Fisher's Exact Test    1.000 .636 
Linear-by-Linear Association .003 1 .954   
N of Valid Cases 47     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.94. 
b. Computed only for a 2x2 table 
Risk Estimate 
 Value 95% Confidence Interval 
Lower Upper 
Odds Ratio for tipe admisi 
(bedah/ nonbedah) 
.948 .160 5.627 
For cohort mortalitas = 
meninggal 
.992 .757 1.300 
For cohort mortalitas = hidup 1.046 .231 4.736 
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